Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Earnings for Arbutus Biopharma (ABUS)
Earnings in 2023 (TTM): -$72.85 M
According to Arbutus Biopharma 's latest financial reports the company's current earnings (TTM) are -$72.85 M. In 2022 the company made an earning of -$65.02 M an increase over its 2021 earnings that were of -$76.25 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Arbutus Biopharma from 2008 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$72.85 M | 12.05% |
| 2022 | -$65.02 M | -14.74% |
| 2021 | -$76.25 M | 19.61% |
| 2020 | -$63.75 M | -61.69% |
| 2019 | -$0.17 B | 171.23% |
| 2018 | -$61.35 M | -43.58% |
| 2017 | -$0.11 B | -77.77% |
| 2016 | -$0.49 B | 532.77% |
| 2015 | -$77.31 M | 99.05% |
| 2014 | -$38.84 M | 175.82% |
| 2013 | -$14.09 M | -143.7% |
| 2012 | $32.22 M | -399.11% |
| 2011 | -$10.78 M | -39.03% |
| 2010 | -$17.67 M | 100.55% |
| 2009 | -$8.82 M | -28.56% |
| 2008 | -$12.34 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -97.03% | Bahamas |
 NRC Health
NRC | $40.82 M | -156.04% | 🇺🇸 USA |